CoChat

Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial

Open access
Papandreou, Christopher, Bulló, Mònica, Zheng, Yan, Ruiz-Canela, Miguel, Yu, Edward, Guasch-Ferré, Marta, Toledo, Estefanía, Clish, Clary, Corella, Dolores, Estruch, Ramon, Ros, Emilio, Fitó, Montserrat, Arós, Fernando, Fiol, Miquel, Lapetra, José, Serra-Majem, Lluís, Gómez-Gracia, Enrique, Liang, Liming, Fragkiadakis, Georgios A, Razquin, Cristina, Hu, Frank B, Salas-Salvadó, Jordi · 2018 · The American Journal of Clinical Nutrition
Cited by 61

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Background The role of trimethylamine-N-oxide (TMAO) in type 2 diabetes (T2D) is currently partially understood and controversial. Objective The aim of this study was to investigate associations between TMAO and related metabolites with T2D risk in subjects at high risk of cardiovascular disease. Design This is a case-cohort design study within the Prevención con Dieta Mediterránea (PREDIMED) study, with 251 incident T2D cases and a random sample of 694 participants (641 noncases and 53 overlapping cases) without T2D at baseline (median follow-up: 3.8 y). We used liquid chromatography-tandem mass spectrometry to measure plasma TMAO, l-carnitine, betaine, lyso-phosphatidylcholine (LPC) and lyso-phosphatidylethanolamine (LPE) species, phosphocholine, α-glycerophosphocholine, and choline at baseline and after 1 y. We examined associations with the use of weighted Cox proportional hazard models, accounting for the weighted case-cohort design by the Barlow method. Results After adjustment for recognized T2D risk factors and multiple testing, individuals in the highest quartile of baseline TMAO and α-glycerophosphocholine had a lower risk of T2D [HR (95% CI): 0.52 (0.29, 0.89) and 0.46 (0.24, 0.89), respectively]. The HR (95% CI) comparing the extreme quartiles of betaine was 0.41 (0.23, 0.74). Similar trends were observed for C16:0 LPC, C18:1 LPC, C18:0 LPC, C20:4 LPC, C22:6 LPC, C18:1 LPC plasmalogen, and C16:0 LPE. After correcting for multiple comparisons, participants in the highest quartile of 1-y changes in oleic acid LPC plasmalogen concentrations had a lower T2D risk than the reference quartile. Conclusion Whether the associations between plasma TMAO and certain metabolite concentrations with T2D risk reflect its pathophysiology or represent an epiphenomenon needs to be elucidated. This trial is registered at http://www.controlled-trials.com as ISRCTN35739639.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajcn/nqy058

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 25 references

Cited by

See all 61

Metadata

Authors
Papandreou, C., Bulló, M., Zheng, Y., Ruiz-Canela, M., Yu, E., Guasch-Ferré, M., Toledo, E., Clish, C., Corella, D., Estruch, R., Ros, E., Fitó, M., Arós, F., Fiol, M., Lapetra, J., Serra-Majem, L., Gómez-Gracia, E., Liang, L., Fragkiadakis, G. A., Razquin, C., Hu, F. B., & Salas-Salvadó, J.
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2018-07
Volume
108
Issue
1
Pages
163-173
ISSN
0002-9165 (ISSN-L)
OpenAlex
W2822651653
Cited by
61
References
25
FWCI
1.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial. https://app.cochat.ai/papers/10.1093/ajcn/nqy058
The paper
Papandreou, C., Bulló, M., Zheng, Y., Ruiz-Canela, M., Yu, E., Guasch-Ferré, M., Toledo, E., Clish, C., Corella, D., Estruch, R., Ros, E., Fitó, M., Arós, F., Fiol, M., Lapetra, J., Serra-Majem, L., Gómez-Gracia, E., Liang, L., Fragkiadakis, G. A., . . . Salas-Salvadó, J. (2018). Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial. The American Journal of Clinical Nutrition. https://doi.org/10.1093/ajcn/nqy058

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.